Paul T. Maruff, Ph.D.

Affiliations: 
CogState, Ltd. 
Google:
"Paul Maruff"
Bio:

Adjunct Prof., University of Melbourne

Mean distance: 106866
 
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

White JP, Schembri A, Prenn-Gologranc C, et al. (2023) Sensitivity of Individual and Composite Test Scores from the Cogstate Brief Battery to Mild Cognitive Impairment and Dementia Due to Alzheimer's Disease. Journal of Alzheimer's Disease : Jad
Jutten RJ, Amariglio RE, Maruff P, et al. (2023) Increased intraindividual variability in reaction time performance is associated with emerging cognitive decline in cognitively unimpaired adults. Neuropsychology
Xia Y, Maruff P, Doré V, et al. (2023) Longitudinal trajectories of basal forebrain volume in normal aging and Alzheimer's disease. Neurobiology of Aging. 132: 120-130
Lim YY, Yassi N, Bransby L, et al. (2023) CSF Aβ and tau biomarkers in cognitively unimpaired Aβ- middle-aged and older APOE ε4 carriers. Neurobiology of Aging. 129: 209-218
Rajendra A, Bondonno NP, Murray K, et al. (2023) Habitual dietary nitrate intake and cognition in the Australian Imaging, Biomarkers and Lifestyle Study of ageing: A prospective cohort study. Clinical Nutrition (Edinburgh, Scotland). 42: 1251-1259
Rabin LA, Sikkes SAM, Tommet D, et al. (2023) Linking self-perceived cognitive functioning questionnaires using item response theory: The subjective cognitive decline initiative. Neuropsychology. 37: 463-499
Pettigrew C, Nazarovs J, Soldan A, et al. (2023) Alzheimer's disease genetic risk and cognitive reserve in relationship to long-term cognitive trajectories among cognitively normal individuals. Alzheimer's Research & Therapy. 15: 66
Bransby L, Rosenich E, Buckley RF, et al. (2023) Multidomain modifiable dementia risk factors are associated with poorer cognition in midlife. Neuropsychology
Williamson M, Maruff P, Schembri A, et al. (2023) Validation of a digit symbol substitution test for use in supervised and unsupervised assessment in mild Alzheimer's disease. Journal of Clinical and Experimental Neuropsychology. 44: 768-779
Jutten RJ, Papp KV, Hendrix S, et al. (2022) Why a clinical trial is as good as its outcome measure: A framework for the selection and use of cognitive outcome measures for clinical trials of Alzheimer's disease. Alzheimer's & Dementia : the Journal of the Alzheimer's Association
See more...